28 related articles for article (PubMed ID: 24126947)
1. Association between CTLA-4 60G/A and -1661A/G polymorphisms and the risk of cancers: a meta-analysis.
Yan Q; Chen P; Lu A; Zhao P; Gu A
PLoS One; 2013; 8(12):e83710. PubMed ID: 24376736
[TBL] [Abstract][Full Text] [Related]
2. Emerging Therapeutic Strategies of Different Immunotherapy Approaches Combined with PD-1/PD-L1 Blockade in Cervical Cancer.
Ge Y; Zhang Y; Zhao KN; Zhu H
Drug Des Devel Ther; 2022; 16():3055-3070. PubMed ID: 36110399
[TBL] [Abstract][Full Text] [Related]
3. Immune Checkpoint Molecules-Inherited Variations as Markers for Cancer Risk.
Wagner M; Jasek M; Karabon L
Front Immunol; 2020; 11():606721. PubMed ID: 33519815
[TBL] [Abstract][Full Text] [Related]
4. CD 152 gene polymorphisms and risk of osteosarcoma in Chinese population.
Chang Z; Song R; Xu S; Xu M; Yu X
Tumour Biol; 2014 Jul; 35(7):6809-14. PubMed ID: 24729087
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis.
Zhang Y; Zhang J; Deng Y; Tian C; Li X; Huang J; Fan H
Cancer; 2011 Sep; 117(18):4312-24. PubMed ID: 21387262
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in cytotoxic T-lymphocyte antigen-4 and susceptibility to cervical cancer.
Xiong YH; He L; Fei J
Int Immunopharmacol; 2014 Jan; 18(1):71-6. PubMed ID: 24201079
[TBL] [Abstract][Full Text] [Related]
7. [Association between cytotoxic T lymphocyte protein-4 polymorphisms and non-Hodgkin's lymphoma risk: a meta-analysis].
Yi B; Pei Y; Wang C; Jiang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1099-104. PubMed ID: 27412943
[TBL] [Abstract][Full Text] [Related]
8. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between cytotoxic T-lymphocyte antigen-4 -318C/T polymorphism and cancer risk: a meta-analysis of case-control studies.
Xia W; Shi R; Zheng WL; Ma WL
Technol Cancer Res Treat; 2013 Dec; 12(6):565-74. PubMed ID: 23745791
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T‑lymphocyte-associated antigen‑4 polymorphisms and susceptibility to cervical cancer: a meta‑analysis.
Qiu H; Tang W; Yin P; Cheng F; Wang L
Mol Med Rep; 2013 Dec; 8(6):1785-94. PubMed ID: 24126947
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T-lymphocyte-associated protein 4 +49A/G polymorphisms contribute to the risk of type 1 diabetes in children: An updated systematic review and meta-analysis with trial sequential analysis.
Wang B; Du W; Jia Y; Zhang X; Ma G
Oncotarget; 2017 Feb; 8(6):10553-10564. PubMed ID: 28060767
[TBL] [Abstract][Full Text] [Related]
12. The association between cytotoxic T lymphocyte-associated antigen-4 and cervical cancer.
Liu P; Xu L; Sun Y; Wang Z
Tumour Biol; 2014 Apr; 35(4):2893-903. PubMed ID: 24317815
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
